HENGRUI PHARMA
01276----
Q3 FY2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: HENGRUI PHARMA(01276) the Revenue is 10.48 B (+29.04%), Beat estimate;the EBIT is 3.317 B (+107.1%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
10.48B29.04%
10.42B28.37%
+0.05B0.67%
EBITExceed expectations
3.32B107.05%
2.55B58.91%
+0.77B48.14%
EPS
TBA--
0.325--
----
Upcoming earnings report - Q3 FY2026
Available dateOct 27, 2026
Estimate Revenue10.42 B
Estimate EBIT--
Estimate EPS0.3264
Revenue
ActualEstimateUnit: HKD
Quarterly
EBIT
ActualEstimateUnit: HKD
Quarterly
Net income
ActualEstimateUnit: HKD
Quarterly
EPS
ActualEstimateUnit: HKD
Quarterly